Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIB4920 in Active Lupus Nephritis
NCT05201469Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2022
- Primary completion
- Jun 2028
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of dazodalibep in lupus nephritis (LN), sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2022; status: recruiting.
02
Drugs
dazodalibep
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT05201469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05201469.